Expanded criteria for hepatocellular carcinoma: Down-staging with a view to liver transplantation - Yes

Seminars in Liver Disease

Volumn 26, Issue 3, 2006, Pages 239-247

  Yao, Francis Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Down staging; Hepatocellular carcinoma; Milan criteria; Orthotopic liver transplantation; University of California San Francisco criteria

Indexed keywords

CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL PROTOCOL; HEALTH CARE DISTRIBUTION; HEALTH CARE POLICY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MILAN CRITERIA; ORGAN DONOR; ORTHOTOPIC TRANSPLANTATION; PATIENT ASSESSMENT; PATIENT CARE PLANNING; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TUMOR VOLUME; UNIVERSITY OF CALIFORNIA SAN FRANCISCO CRITERIA;

CARCINOMA, HEPATOCELLULAR; CLINICAL PROTOCOLS; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; PATIENT SELECTION;

EID: 33746566596     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947295     Document Type: Review

References (45)

1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699
2. Befeler AS, Hayashi PH, Di Bisceglie AM. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2005;128:1752-1764
3. United Network for Organ Sharing, Policy 3.6. Available at: http://www.unos.org/policiesandbylaws/policies.asp?resources=true. Accessed February 6, 2006
4. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004;127(suppl 1):S261-S267
5. Broelsch CE, Frilling A, Malago M. Should we expand the criteria for liver transplantation for hepatocellular carcinoma-yes, of course! J Hepatol 2005;43:569-573
6. Hiatt JR, Carmody IC, Busuttil RW. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?-no, never. J Hepatol 2005;43:573-577
7. Bruix J, Fuster J, Llovet J. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003;9:700-702
8. Roayaie S, Llovet JM. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified? Clin Liver Dis 2005;9:315-328
9. Eng SC, Kowdley KV. Expansion of criteria for liver transplantation in HCC: a slippery slope? Gastroenterology 2002;122:579-582
10. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127(suppl 1):S27-S34
11. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403
12. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765-774
13. Herrero JI, Sangro B, Quiroga J, et al. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001;7:631-636
14. Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 2003;9:693-696
15. Leung JY, Zhu AX, Gordon FD, et al. Liver transplantation for early-stage hepatocellular carcinoma: results of a multi-center study. Liver Transpl 2004;10:1343-1354
16. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, et al. What is the impact of UCSF expansion criteria according to pre-liver transplantation tumor characteristics on survival: results from 14 French centers [abstract]. Hepatology 2004; 40(suppl 1):550A
17. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2004;127(suppl 1):S268-S276
18. Hwang S, Lee SG, Joh JW, et al. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantation. Liver Transpl 2005;11:1265-1272
19. Shetty K, Timmins K, Brensinger C, et al. Liver transplantation for hepatocellular carcinoma: validation of the present selection criteria in predicting outcome. Liver Transpl 2004;10:911-918
20. Yao FY, Roberts JP. Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time? Liver Transpl 2004;10:919-921
21. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: a 4-year prospective study validating expanded criteria based on pre-operative staging [abstract]. Hepatology 2005;42(suppl 1):197A
22. Sala M, Varela M, Bruix J. Selection of candidates with HCC for transplantation in the MELD era. Liver Transpl 2004;10:S4-S9
23. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086
24. Hemming AW, Cattral MS, Reed AI, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-659
25. De Carlis L, Glacomoni A, Laanterio A, et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int 2003;16:115-122
26. Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment of moderately or well differentiated hepatocellular carcinoma. Ann Surg 2004;239:150-159
27. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-701
28. Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003;9:557-563
29. Llovet JM, Mas X, Aponte JJ, et al. Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma before liver transplantation. Gut 2002;50:123-128
30. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900-909
31. Yao FY, Kinkhabwala M, LaBerge JM, et al. The impact of pre-operative loco-regional treatments on survival following liver transplantation for hepatocellular carcinoma. Am J Transplant 2005;5:795-804
32. Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41:1130-1137
33. Yao FY, Ferrell LD, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: the impact of the degree of tumor necrosis from pre-operative loco-regional therapy on recurrence [abstract]. Gastroenterology 2005;128(suppl 2):A689
34. Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004;10:36-41
35. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the model of end-stage liver disease (MELD) organ allocation policy. Liver Transpl 2004;10:621-630
36. Maddala YK, Stadheim L, Andrews JC, et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004;10:449-455
37. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma larger than 5 centimeters. Ann Surg 2002;235:533-539
38. Yao FY, Hirose R, LaBerge J, et al. A prospective study on down-staging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005;11:1505-1514
39. Marsh JW, Dvorchik I, Iwatsuki S. UNOS policy in upgrading patients with HCC awaiting liver transplantation: too little too late [abstract]. Transplantation 2000;69(suppl):S139
40. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-524
41. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649
42. Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004; 127:1714-1723
43. Sala M, Llovet JM, Vilana Ret alfor the Barcelona Clinic Liver Cancer Group. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-1360
44. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004;127(suppl 1):S159-S166
45. Marsh JW, Finkelstein SD, Demetris AJ, et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl 2003;9:664-671